GORE HELEX Septal Occluder HX2025Recalls & reported problems
W. L. Gore & Associates, Inc. · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00733132606993), received between Jan 10, 2019 and Jun 5, 2024 — classified as 3 injuries.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Device Dislodged or Dislocated1
- Patient Device Interaction Problem1
Patient problems
- Endocarditis1
- No Code Available1
- Stroke/CVA1
- Thrombus1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJun 5, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED A GORE® HELEX SEPTAL OCCLUDER WAS IMPLANTED ON (B)(6) 2014 TO CLOSE AN ATRIAL SEPTAL DEFECT. THE PATIENT GOT A VIRAL INFECTION WHILE ON A CRUISE. AFTER THEY GOT BACK, THEIR PHYSICIAN FOUND A LARGE MASS ON THE LEFT DISC OF THE DEVICE. THE MASS WAS DESCRIBED AS VEGETATIVE GROWTH. ON (B)(6) 2024, IN A SURGICAL PROCEDURE, THE DEVICE WAS REMOVED, AND THE DEFECT WAS CLOSED WITH A PATCH. THE PATIENT WAS DOING WELL FOLLOWING THE PROCEDURE.
Patient problems: Endocarditis
MAUDE report 19471921 ↗InjuryJul 1, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THE PHYSICIAN IMPLANTED A 25MM GORE® HELEX® SEPTAL OCCLUDER TO CLOSE A PATENT FORAMEN OVALE ON (B)(6) 2014 IN A PATIENT WITH A HISTORY OF STROKE. ON (B)(6) 2019, THE PATIENT PRESENTED WITH A STROKE. TRANSESOPHAGEAL IMAGING PERFORMED ON (B)(6) 2019 SHOWED A THROMBUS ON THE LEFT SIDE OF THE HELEX® DEVICE. THE PATIENT WAS LOST TO FOLLOW-UP AFTER THE HELEX® IMPLANT AND REPORTED HE HAS NOT BEEN COMPLIANT WITH THE RECOMMENDED ANTICOAGULANTS. THE PATIENT WAS PRESCRIBED ANTICOAGULANTS AND SCHEDULED FOR FOLLOW-UP IN ONE MONTH. IN (B)(6) 2019, THE PATIENT PRESENTED WITH ANOTHER STROKE AND LEFT SIDE PARALYSIS. THE PATIENT WAS DISCHARGED UNDER HOSPICE CARE.
Patient problems: Stroke/CVA; Thrombus
MAUDE report 8749415 ↗InjuryJan 10, 2019Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED A PATIENT RECEIVED A GORE® HELEX® SEPTAL OCCLUDER IMPLANT IN 2015 TO TREAT A PATENT FORAMEN OVALE. APPROXIMATELY TWO MONTHS AGO A SIGNIFICANT SHUNT WAS NOTED AND IT APPEARED AS THOUGH A COUPLE OF THE RIGHT DISC LEAFLETS HAD PROLAPSED. A 25MM GORE® CARDIOFORM SEPTAL OCCLUDER WAS SELECTED TO CLOSE THE SHUNT; HOWEVER, FOLLOWING DEPLOYMENT A SIGNIFICANT RESIDUAL SHUNT WAS NOTED ON ECHOCARDIOGRAPHY AND THE DEVICE WAS REMOVED. A 30MM GORE® CARDIOFORM SEPTAL OCCLUDER WAS THEN SELECTED, HOWEVER, WHEN THE DEVICE WAS LOCKED, FLUOROSCOPY REVEALED A MISSED RIGHT ATRIAL EYELET. THIS DEVICE WAS REMOVED AND A SECOND 30MM GORE® CARDIOFORM SEPTAL OCCLUDER WAS SUCCESSFULLY IMPLANTED. THE GORE® HELEX® SEPTAL OCCLUDER ALSO REMAINS IMPLANTED. FURTHER DISCUSSION BETWEEN THE FIELD SALES ASSOCIATE AND THE PHYSICIAN INDICATED IT WAS FELT THAT THIS WAS ANOTHER DEFECT/FENESTRATION; HOWEVER, THIS HAS NOT BEEN CONFIRMED.
Patient problems: No Code Available
MAUDE report 8233140 ↗
Other Transcatheter Septal Occluder devices
- Amplatzer™ Septal OccluderAga Medical Corporation · Transcatheter septal occluder294 reports
- Amplatzer™ Septal OccluderAga Medical Corporation · Transcatheter septal occluder1 death213 reports
- Amplatzer™ Talisman™ 9-PFO-3025St. Jude Medical, Inc. · Transcatheter septal occluder1 death193 reports
- GORE CARDIOFORM Septal Occluder GSX0030AW. L. Gore & Associates, Inc. · Transcatheter Septal Occluder1 recall143 reports
- Amplatzer™ 9-ASD-MF-025St. Jude Medical, Inc. · Transcatheter septal occluder1 death183 reports
- Amplatzer™ PFO OccluderSt. Jude Medical, Inc. · Transcatheter septal occluder1 death153 reports
- Amplatzer™ 9-ASD-MF-030St. Jude Medical, Inc. · Transcatheter septal occluder149 reports
- Amplatzer™ Talisman™ 9-PFO-2518St. Jude Medical, Inc. · Transcatheter septal occluder139 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page